Table 1.
Overview of the newly identified transporters of iodothyronines and/or iodothyronine sulfates in mouse and human SLC22 family. For the specificity and efficacy of lesinurad and probenecid, IC50 values were listed. SLC22A9, SLC22A11 and SLC22A24 are human specific, whereas SLC22A19, SLC22A26-30 are mouse specific.
| Mouse | Human | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Transporter | Substrates | Expression in tissuesa | Substrate tested for inhibition | Lesinurad IC50 | Probenecid IC50 | Substrates | Expression in tissuesb | Substrate tested for inhibition | Lesinurad IC50 | Probenecid IC50 |
| SLC22A8 | 3,3'-T2, rT3, T3, T4, T3S, T4S | Kidney, frontal lobe, brain (endothelial cells)c | T4 | 1.3 μM | 6.0 μM | 3,3'-T2, rT3, T3, T4, T3S, T4S | Kidney, choroid plexus | T3S | 0.6 μM | 3.5 μM |
| SLC22A9 | Not in mouse | T3, T4, T3S, T4S | Liver | T3S | 50 μM | 413 μM | ||||
| SLC22A11 | Not in mouse | T4, T3S | Placenta, kidney, epididymis | T4 | 8.8 μM | 57 μM | ||||
| SLC22A19 | T4 | Kidney | T4 | 5.4 μM | 773 μM | Not in human | ||||
| SLC22A24 | Not in mouse | T4 | Kidney | T3Sd | 11 μM | 24 μM | ||||
| SLC22A26 | rT3, T4, T4S | Liver | T4 | 17 μM | x | Not in human | ||||
| SLC22A27 | 3, 3'-T2, rT3, T3, T4, T3S, T4S | Liver | T4 | x | x | Not in human | ||||
| SLC22A28 | T3, T4 | Liver, kidney | T4 | 26 μM | >>1000 μM | Not in human | ||||
| SLC22A29 | rT3, T3, T4, T3S, T4S | Kidney | T4 | x | x | Not in human | ||||
| SLC22A30 | T3, T4 | Liver | T4 | x | x | Not in human | ||||
aThe tissue expression in mouse was adopted from the mouse ENCODE transcriptome data project (‘A comparative encyclopedia of DNA elements in the mouse genome’ by Yue et al. in 2014) (34). Expression less than five reads per kilo base per million mapped reads (RPKM) are neglected; bThe tissue expression in human was adopted from the HPA datasets from https://www.proteinatlas.org/. Expression less than three transcripts per million (TPM) are neglected; cCell-specific expression in brain was adopted from http://www.brainrnaseq.org/; dT3S was used as the substrate to test for inhibition effect because hSLC22A24 induced T3S uptake more robustly though the induction did not reach statistical significance.
>>1000 μM means within the tested doses, IC50 was not reached; N.T., not tested; X, no inhibition effect.
This work is licensed under a